OGN
Organon & Co.
NYSE · Healthcare · Drug Manufacturers - General · US
$13.78
+0.04%Forward multiples
Based on analyst estimates
- P/E forward
- 3.96x
- P/E 2026E
- 4.11x
- P/E 2027E
- 3.79x
- P/E 2028E
- 3.44x
- P/S forward
- 0.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.44x
- PEG TTM
- 0.05x
- Price / book
- 3.60x
- Price / sales
- 0.59x
- Price / cash flow
- 4.91x
Enterprise value
- Enterprise value
- $11.0B
- EV / sales
- 1.80x
- EV / EBITDA
- 8.45x
- EV / EBIT
- 9.34x
- Market cap
- $3.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026